TOVX
Theriva Biologics·AMEX
--
--(--)
--
--(--)
TOVX Filings
Filing Date
Form Description
Form Type
2026-03-23
Form 8-K - Current report
Key Events
2026-03-23 · Key Events
Form 8-K - Current report
2026-03-16
Form DEF 14A - Other definitive proxy statements
Key Events
2026-03-16 · Key Events
Form DEF 14A - Other definitive proxy statements
2026-03-12
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-12 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-12
Form 8-K - Current report
Key Events
2026-03-12 · Key Events
Form 8-K - Current report
2026-03-04
Form PRE 14A - Other preliminary proxy statements
Key Events
2026-03-04 · Key Events
Form PRE 14A - Other preliminary proxy statements
2026-02-18
Form 8-K - Current report
Key Events
2026-02-18 · Key Events
Form 8-K - Current report
2026-02-12
Form 8-K - Current report
Key Events
2026-02-12 · Key Events
Form 8-K - Current report
2026-01-12
Form 8-K - Current report
Key Events
2026-01-12 · Key Events
Form 8-K - Current report
2026-01-06
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-06 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-06
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-06 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
